Tag: Biontech
Pfizer Chief Scientific Officer: after six months there likely is the risk of coronavirus reinfection as antibodies wane
Pfizer Chief Scientific Officer Mikael Dolsten said the recently reported dip in the vaccine’s effectiveness in Israel was mostly due to infections in people who had been vaccinated in January or February. More...
Israel: 62 cases of myocarditis following Pfizer coronavirus vaccination
About one in 100,000 people who received the Pfizer coronavirus vaccine suffered from myocarditis (inflammation of the heart muscle) – a preliminary report by the committee of experts tasked by the Health Ministry to monitor the vaccine’s side effects has found. More...
CDC: Moderna’s COVID-19 coronavirus vaccine could lead to more side effects than Pfizer/BioNTech’s
New research from the U.S. Centers for Disease Control and Prevention suggests that people who receive Moderna’s COVID-19 vaccine might experience more side effects than those who get Pfizer/BioNTech’s vaccine. More...
Switzerland: Stage III hypertension in patients after mRNA-based SARS-CoV-2 coronavirus vaccination with Pfizer/Biontech & Moderna
On January 11th 2021, the vaccination Center in Lausanne, a city of 140’000 inhabitants in western Switzerland, started the COVID-19 vaccination with mRNA-based vaccines. More...
Germany: no second AstraZeneca coronavirus vaccination for under 60’s – mRNA recommended instead
The German Standing Vaccination Commission recommends that people under the age of 60 for a should receive an RNA vaccine such as that from BioNTech for their second vaccination. More...
Hong Kong, Macau suspend Pfizer-BioNTech coronavirus vaccine over ‘flawed’ vials
Hong Kong and Macau suspended the use of Pfizer-BioNTech’s COVID-19 vaccine on Wednesday (Mar 24 2021) after being informed of a packaging problem affecting one batch of vials, while stressing they did not believe there was a safety risk. More...
Norway investigates 23 deaths of frail elderly patients after Pfizer vaccination
Doctors in Norway have been told to conduct more thorough evaluations of very frail elderly patients in line to receive the Pfizer BioNTec vaccine against covid-19, following the deaths of 23 patients shortly after receiving the vaccine. More...
CDC: Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech coronavirus vaccine
“During December 14–23, 2020, monitoring by the Vaccine Adverse Event Reporting System detected 21 cases of anaphylaxis after administration of a reported 1,893,360 first doses of the Pfizer-BioNTech COVID-19 vaccine (11.1 cases per million doses); 71% of these occurred within 15 minutes of vaccination.” More...
Italian vaccinated with Pfizer/Biontech vaccine is infected with Brazilian coronavirus variant 501YV2
A health professional at a hospital in L’Aquila, Italy, was infected with the variant Brazilian P.1 of the new coronavirus, even after being immunized with the vacina pharmaceutical company Pfizer in partnership with BioNTech. More...
Single Pfizer vaccine shot 90 per cent effective after 21 days
A single dose of the Pfizer vaccine provides “very high” protection from Covid-19 after 21 days – without a ‘top up’ dose in the recommended time frame, according to a new study from the University of East Anglia. More...